Alexion Pharmaceuticals
UEI: DZ9QEG2B98V6
Overview
Awardee Type
Parent
(3 children)
Company Description
Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.
Name
Alexion Pharmaceuticals
Website
Headquarters
Boston, MA
United States
United States
Most Recent Award
Aug. 8, 2026
Calculating
Alexion Pharmaceuticals is a federal contract and grant recipient (UEI DZ9QEG2B98V6). It has also received state and local contract awards. The associated registration for ALEXION PHARMACEUTICALS INC lists its headquarters in Boston, MA. The associated registration's primary registered NAICS is 325412: Pharmaceutical Preparation Manufacturing. The corporation in the associated registration was founded in January 1992 and federally registered in April 2026. This parent-awardee profile has 3 associated child awardees.
Federal Award Analysis
Alexion Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
This Parent entity does not have an associated active registration. Showing registration information for UEI DKCXLGANZAN3 CAGE 4EXK1 instead.
Legal Name
ALEXION PHARMACEUTICALS INC
DBA
ALEXION PHARMACEUTICALS INC
UEI
DKCXLGANZAN3
CAGE Code
4EXK1
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 28, 1992
Initial Registration
April 17, 2026
Last Registration
April 29, 2026
Registration Activation
April 29, 2026
Registration Expiration
April 27, 2027
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Alexion Pharmaceuticals
GSA Schedules and Price Lists
- Alexion Pharmaceuticals
- PoP: 6/14/26 - 6/14/31
- Astrazeneca Pharmaceuticals Lp
- PoP: 9/29/19 - 9/30/27
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $43,631
- Alexion Pharmaceuticals
- PoP: 3/31/18 - 6/15/26 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $3,264,817
Contract Vehicles
Alexion Pharmaceuticals multi-award contract vehicles
IDV Awards
Alexion Pharmaceuticals indefinite delivery vehicle awards
Contract Awards
Alexion Pharmaceuticals prime contract awards
Grant Awards
Alexion Pharmaceuticals direct grants
Subgrant Awards
Alexion Pharmaceuticals subgrant awards
State and Local Awards
Alexion Pharmaceuticals state and local contract awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Alexion Pharmaceuticals
Additional Analysis
Federal Contract Opportunities Requiring Similar Experience
State and Local Opportunities Requiring Similar Experience
Top Contracting Officers Buying from Awardee
Federal Contracts Recompeting Soon
Federal Grants Recompeting Soon
Market Size Analysis
Active Federal Opportunities for Registered NAICS
State and Local Opportunities Requiring Similar Experience
Top Contracting Officers Buying from Awardee
Federal Contracts Recompeting Soon
Federal Grants Recompeting Soon
Market Size Analysis
Active Federal Opportunities for Registered NAICS